Measurements of serum mullerian inhibiting substance in the evaluation of children with nonpalpable gonads
Authors
Lee, Mary M.Donahoe, Patricia K.
Silverman, B. L.
Hasegawa, T.
Hasegawa, Yasuhiro
Gustafson, M. L.
Chang, Y. C.
MacLaughlin, David T.
UMass Chan Affiliations
Department of PediatricsDocument Type
Journal ArticlePublication Date
1997-05-22Keywords
Anti-Mullerian HormoneChild
Child, Preschool
Cryptorchidism
Diagnosis, Differential
Disorders of Sex Development
Female
*Glycoproteins
Growth Inhibitors
Humans
Infant
Infant, Newborn
Male
Mullerian Ducts
Sensitivity and Specificity
Testicular Hormones
Testis
Testosterone
Virilism
Mullerian inhibiting substance
serum concentration
Cell Biology
Developmental Biology
Endocrinology
Endocrinology, Diabetes, and Metabolism
Metadata
Show full item recordAbstract
BACKGROUND: Mullerian inhibiting substance, produced constitutively by the prepubertal testes, promotes involution of the mullerian ducts during normal male sexual differentiation. In children with virilization and nonpalpable gonads, only those with testicular tissue should have detectable serum concentrations of mullerian inhibiting substance. METHODS: We measured serum mullerian inhibiting substance in 65 children with virilization at birth and nonpalpable gonads (age at diagnosis, 2 days to 11 years) and serum testosterone in 54 of them either after the administration of human chorionic gonadotropin or during the physiologic rise in testosterone that occurs in normal infants. RESULTS: The mean (+/-SD) serum mullerian inhibiting substance concentration in the 17 children with no testicular tissue was 0.7+/-0.5 ng per milliliter, as compared with 37.5+/-39.6 ng per milliliter in the 48 children with testes (P CONCLUSIONS: Measurements of serum mullerian inhibiting substance can be used to determine testicular status in prepubertal children with nonpalpable gonads, thus differentiating anorchia from undescended testes in boys with bilateral cryptorchidism and serving as a measure of testicular integrity in children with intersexual anomalies.Source
Lee MM, Donahoe PK, Silverman BL, Hasegawa T, Hasegawa Y, Gustafson ML, Chang YC, MacLaughlin DT. Measurements of serum müllerian inhibiting substance in the evaluation of children with nonpalpable gonads. N Engl J Med. 1997 May 22;336(21):1480-6. doi: 10.1056/NEJM199705223362102. PMID: 9154766. Link to article on publisher's site
DOI
10.1056/NEJM199705223362102Permanent Link to this Item
http://hdl.handle.net/20.500.14038/36061PubMed ID
9154766Notes
At the time of publication, Mary Lee was not yet affiliated with the University of Massachusetts Medical School.
Related Resources
Rights
Copyright © 1997 Massachusetts Medical Society. Published article PDF archived as allowed by the publisher's author permissions policy at https://www.nejm.org/author-center/permissions.ae974a485f413a2113503eed53cd6c53
10.1056/NEJM199705223362102
